Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New app helps families spot and stop delirium in dementia patients

NCT ID NCT05630014

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study created and tested a mobile health program for family caregivers of people with dementia who are at risk for delirium—a sudden, serious confusion. Researchers worked with 8 caregivers to design the program, then tested it with 33 caregivers to see if it was easy to use and helpful. The goal was to see if the program could help caregivers feel more confident in detecting, preventing, and managing delirium at home.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

33 people

The number who actually took part.

Started

Dec 2023

Finished

Feb 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: To be eligible as a "dementia caregiver" in the co-design workshop, an individual must: * be at least 18 years old, * be English-speaking, * provide at least 8 hours of unpaid care weekly or live with a community-dwelling PLWD, * self-identify as unfamiliar with DSD, * have the capacity to consent, and * have Internet access To be eligible as a "DSD caregiver" in the co-design workshop, an individual must: * be at least 18 years old, * be English-speaking, * be a current or past dementia caregiver with experience caring for a relative or friend during his/her DSD episode within the past 12 months, * have the capacity to consent, and * have Internet access. To be eligible to participate in the feasibility trial, an individual must meet all of the following criteria: * Being 18 years old or older, * English-speaking, * Providing at least 8 hours of unpaid care per week to, or living with, a community dwelling PLWD whose Delirium Risk Assessment Score \>=5, * Having the capacity to give informed consent, and * Having a smartphone with Internet access. Exclusion Criteria: * Individuals who are blind or deaf will be excluded.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Delirium superimposed on dementia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • NYU Langone Health

    New York, New York, 10010, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, 15260, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.